Home » Stocks » BPMX

BioPharmX Corporation (BPMX)

May 19, 2020 - BPMX merged into TMBR
Stock Price: $0.510 USD 0.000 (0.00%)
Updated May 18, 2020 4:00 PM EDT
Market Cap 776,821
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 18.28M
EPS (ttm) -0.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 18, 2020
Last Price $0.510
Previous Close $0.510
Change ($) 0.000
Change (%) 0.00%
Day's Open -
Day's Range 0.456 - 0.525
Day's Volume 0
52-Week Range 0.250 - 1.180

News

Benzinga - 1 year ago

Biopharmx Corp shares spiked higher Tuesday morning after the company announced its Phase 2b trial of BPX-04 for Populopustular Rosacea has met both primary and secondary endpoints and was wel...

About BPMX

BioPharmX Corporation, a specialty pharmaceutical company, develops products for the treatment of dermatologic conditions using its proprietary HyantX topical delivery system. Its clinical-stage product candidates include BPX01, a topical antibiotic gel that has completed Phase IIb clinical trials for the treatment of inflammatory lesions of acne; and BPX04, a topical antibiotic, which is in Phase IIb study for the treatment of inflammatory lesions of papulopustular rosacea. The company serves pharmaceutical companies, physician's practices, de... [Read more...]

Industry
Biotechnology
Founded
2014
CEO
Steven M. Bosacki
Employees
3
Stock Exchange
NYSE American
Ticker Symbol
BPMX
Full Company Profile